MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-11-0015733
Jaggi Enterprises Private Limited
Jaggi Enterprises Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹123.9 Cr
▲ 8% YoY
Net loss · FY 2025
₹4.06 Cr
Net margin -3.3%
EBITDA · FY 2025
-₹33.5 Lakh
EBITDA margin -0.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹12 Cr
Secured borrowings
Company age
9 yrs
Est. 2017
Employees · EPFO
146
Provident fund records
About Jaggi Enterprises Private Limited
Data last updated:
Jaggi Enterprises Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Entero Healthcare Solutions Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC317744. Its GSTIN is 07AADCJ9818K1Z3 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sharad Jaiswal and Amitabh Bhatnagar.
Its last annual general meeting (AGM) was held on 17 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 7 First Floor, Mayapuri Industrial Area Phase – II, New Delhi, Delhi, India – 110064.
As per the financials filed for FY 2025, the company reported a revenue of ₹123.9 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net loss of ₹4.06 Cr (net margin -3.3%) and EBITDA of -₹33.5 Lakh (EBITDA margin -0.3%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 18% over five years.
The company has about 146 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹12 Cr on record. Court records list 8 cases involving the company, including 6 filed by the company and 2 filed against it; 3 cases are pending. The company has 1 deal on record (1 secondary share transfer); the latest was in March 2019. Its 6 peer companies in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 2 larger and 4 smaller; the largest is Care Formulation Labs Private Limited with revenue of ₹125.33 Cr.
Jaggi Enterprises Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0015733). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999DL2017PTC317744
Registration Number 317744
Incorporation Date 18 May 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 17 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Entero Healthcare Solutions Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DL-11-0015733
Key People
Sharad Jaiswal Additional Director Amitabh Bhatnagar Additional Director Amar Nath Lalka Additional Director Recognitions & Rankings of Jaggi Enterprises
Contact details
Jaggi Enterprises Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 7 First Floor, Mayapuri Industrial Area Phase – II, New Delhi, Delhi, India – 110064
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Jaggi Enterprises Private Limited, buy the company report.
Comprehensive company report
Jaggi Enterprises Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Jaggi Enterprises is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Jaggi Enterprises Private Limited, buy the company report.
Financials of Jaggi Enterprises Private Limited
FY 2025 filings availableJaggi Enterprises Private Limited reported revenue of ₹123.9 Cr (up 8% YoY) for FY 2025.
Revenue · FY 2025
₹123.9 Cr ▲ 8%
Net loss · FY 2025
₹4.06 Cr margin -3.3%
EBITDA · FY 2025
-₹33.5 Lakh margin -0.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 7%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▼ 120%
3 years · compounded
▼ 28%
5 years · compounded
▼ 18%
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 8% growth in the latest year. EBITDA fell 120% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹33.5 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.06 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.3% | ||||
| Net Profit Margin | -3.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jaggi Enterprises Private Limited, buy the company report.
Board of directors of Jaggi Enterprises Private Limited
Jaggi Enterprises has 4 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sharad Jaiswal | Additional Director | 29 Nov 2025 | 0 Years 11 Months | Current |
| Amitabh Bhatnagar Also directs: Sharamit Enterprises Private Limited | Additional Director | 20 Sep 2025 | 1 Years 1 Months | Current |
| Amar Nath Lalka | Additional Director | 26 May 2025 | 1 Years 5 Months | Current |
| Ganesh Kumar | Additional Director | 24 Jan 2025 | 1 Years 9 Months | Current |
Peer comparison
Jaggi Enterprises Private Limited is compared with the 6 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Care Formulation Labs Private Limited | ₹125.33 Cr (FY 2025) | 19.0% | New Delhi, Delhi, India | |||
| Vatech India Private Limited | ₹125.12 Cr (FY 2025) | -9.0% | Delhi, India | |||
| Jaggi Enterprises Private Limitedthis company | ₹123.9 Cr (FY 2025) | -₹4.06 Cr | -3.3% | 8.0% | 146 | New Delhi, Delhi, India |
| Kaafi Enterprises Private Limited | ₹122.9 Cr (FY 2024) | 2.0% | Mumbai, Maharashtra, India | |||
| B M Chemie Private Limited | ₹121.23 Cr (FY 2025) | 2752.0% | Mumbai, Maharashtra, India | |||
| Shri Bhakti Medical Agencies Private Limited | ₹120.88 Cr (FY 2025) | 19.0% | Chennai, Tamil Nadu, India | |||
| Singlamedicos Pharma Solutions Private Limited | ₹120.59 Cr (FY 2025) | 26.0% | Chandigarh, India |
To see the full peer comparison of Jaggi Enterprises Private Limited, buy the company report.
Auditor
Jaggi Enterprises Private Limited is audited by M S K A & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M S K A & Associates | FY 2023 | 105047W |
Shareholding
The shareholding of Jaggi Enterprises Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Jaggi Enterprises Private Limited, buy the company report.
Charges & borrowings
Open charges
₹12 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Oct 2020 | 100395429 | Others | ₹12 Cr | Open |
To see the full charge records of Jaggi Enterprises Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Jaggi Enterprises Private Limited has 1 deal on record (1 secondary share transfer); the latest was in March 2019.
Total deals
1
Secondary share transfer
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: Entero Healthcare Solutions Private Limited, Entero Healthcare Solutions Private Limited & Prabhat Agrawal Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Jaggi Enterprises Private Limited has 8 court cases on record: 6 filed by Jaggi Enterprises, 2 filed against it. 3 cases are pending and 5 are disposed.
Total cases
8
Filed by the company
6
Filed against the company
2
Pending
3
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 2 | 3 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against Adrian Lifescience Private Limited and 2 others | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against Fenway Pharmaceuticals Private Limited and 2 others | Disposed |
| District court, Central, Delhi | Court case (L I D) | Filed against the company by an individual | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, South West, Delhi | Civil suit | Filed against the company by State | Disposed |
To see the full case history of Jaggi Enterprises Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jaggi Enterprises Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Jaggi Enterprises Private Limited has a workforce of 146 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.
Employee count
146
Active EPFO establishments
1
Employee growth
7.35%
GST
Jaggi Enterprises has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCJ9818K1Z3 | Delhi | Active | 01 Mar 2019 |
To see the full GST registrations and return filing status of Jaggi Enterprises Private Limited, buy the company report.
Recent activity
Jaggi Enterprises Private Limited has 14 board changes on record since 2019: 4 appointments and 10 cessations. The latest: Sharad Jaiswal was appointed as Additional Director on 29 Nov 2025.
Appointed
Sharad Jaiswal was appointed as Additional Director.
Appointed
Amitabh Bhatnagar was appointed as Additional Director.
AGM
Jaggi Enterprises Private Limited last Annual general meeting of members was held on 17 Sep 2025 as per latest MCA records.
Ceased
Amar Nath Lalka ceased to be Additional Director.
Ceased
Ganesh Kumar ceased to be Additional Director.
Appointed
Amar Nath Lalka was appointed as Additional Director.
Ceased
Sharad . Jaiswal ceased to be Additional Director.
Filing
Jaggi Enterprises Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Ganesh Kumar was appointed as Additional Director.
Ceased
Anshdeep Singh ceased to be Additional Director.
Ceased
Hemant Jaggi ceased to be Director.
Ceased
Alikesh Awasthi ceased to be Additional Director.
7 earlier events are in the company report.
Frequently asked questions
Jaggi Enterprises is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 May 2017 (9+ years old) and is registered under CIN U74999DL2017PTC317744.
Jaggi Enterprises has 4 current directors:
- Sharad Jaiswal - Additional Director
- Amitabh Bhatnagar - Additional Director
- Amar Nath Lalka - Additional Director
- Ganesh Kumar - Additional Director
The latest financial statements of Jaggi Enterprises on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 17 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Jaggi Enterprises is 07AADCJ9818K1Z3, registered in Delhi.
The CIN (Corporate Identification Number) of Jaggi Enterprises is U74999DL2017PTC317744. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jaggi Enterprises has 8 court cases on record: 6 filed by the company and 2 filed against it. 3 are pending.
Jaggi Enterprises was incorporated on 18 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Jaggi Enterprises has 1 deal on record (1 secondary share transfer); the latest was in March 2019.
The peers of Jaggi Enterprises by revenue are Care Formulation Labs Private Limited, Vatech India Private Limited, Kaafi Enterprises Private Limited, B M Chemie Private Limited, Shri Bhakti Medical Agencies Private Limited and 1 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Sharad Jaiswal was appointed as Additional Director on 29 Nov 2025. Amitabh Bhatnagar was appointed as Additional Director on 20 Sep 2025. Amar Nath Lalka ceased to be Additional Director on 16 Sep 2025. Jaggi Enterprises has 14 board changes on record in total.
Yes, Jaggi Enterprises is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-11-0015733).